Link to Article

NYTimes.com

Link to All Articles

Dec 20 2007, 12:21 PM EST
Human Genome Sciences Will Pay up to $310M for Aegera's Anticancer Agent
HGS could also gain related IAP antagonists, and Aegera retains Japanese rights to already licensed preclinical candidate. Full Story

Dec 20 2007, 12:23 PM EST
Over 50 New Breast Cancer Biomarkers Discovered
A study reported in PLoS ONE found that a single differentially methylated locus showed a clinical sensitivity of 90% and a specificity of 96% for infiltrating ductal breast carcinoma. Full Story

Dec 19 2007, 11:54 AM EST
deCODE to Coestablish the Seattle Structural Genomics Center for Infectious Diseases with $13.5M Award
Funding from the SBRI will go toward determining structures of proteins related to emerging or re-emerging infectious diseases. Full Story

Dec 19 2007, 11:51 AM EST
Cancer Therapeutics and an Australian Medical Institute Join Forces to Develop Anticancer Drugs against Unique Target
Collaboration will focus on designing a small molecule to inhibit a protein, discovered by QIMR, that is linked to cancer survival. Full Story

Dec 18 2007, 12:01 PM EST
Pfizer to Acquire CovX to Bolster Biologics Pipeline
Firm thus gains three clinical compounds and a technology that extends the half-life of peptide treatments. Full Story

Dec 18 2007, 12:04 PM EST
Affymetrix to Purchase USB for $75M
USB's expertise in reagents will aid company's efforts to provide new genetic analysis tests. Full Story

Dec 18 2007, 12:06 PM EST
Lilly Coughs Up $87M Upfront for BioMS Medical's MS Candidate
BioMS could earn up to $410 million in milestone fees plus royalties on MBP8298, which is in mid- and late-stage trials. Full Story

Dec 17 2007, 11:17 AM EST
Oxford Genome Sciences Allies with Amgen on Cancer Therapeutics
Companies will generate fully human antibodies against OGeS-identified druggable targets using Amgen's XenoMouse platform. Full Story

Dec 14 2007, 12:08 PM EST
Alba Inks $325M Deal with Shire to Develop Its Lead Candidate for GI Disorders
Alba will receive $25 million upfront and the rest in milestone fees. Full Story

GenEngNews.com

Link to All Articles

Dec 13 2007, 11:27 AM EST
Regulus Therapeutics and Duke Univ. Find that Viral miRNAs Mimic Human miRNAs
Research reported in Nature found a virally derived miRNA that seems to control some cancers, suggesting the first oncomir. Full Story

Dec 12 2007, 12:07 PM EST
Merck & Co. Doles Out $6M in Milestone Payments for Cancer Vaccine Advancement
IND filings spur fees to Inovio and Geron. Full Story

Dec 11 2007, 12:30 PM EST
Epigenetic Cancers Are Spurred by Growth Factors
Study that will be reported in PNAS also found that blocking the ability to respond to IGF-II reduces risk of colon cancer. Full Story

Dec 11 2007, 12:29 PM EST
Millipore and Novozymes Ink Deal Related to Cell Culture Supplements
Companies will supply animal-free products for bioprocessing. Full Story

Dec 11 2007, 12:34 PM EST
Inverness Announces Tenth Acquisition of the Year
Firm proposes to buy out BBI Holdings for over $141 million, topping off the $2 billion it has already spent this year on take overs. Full Story

Dec 10 2007, 01:12 PM EST
OncoMed Signs $1.4B Alliance with GSK Focusing on Cancer Stem Cells
GSK has the option to four compounds directed at multiple targets. Full Story

Dec 10 2007, 01:05 PM EST
GE and Novavax Join Forces to Come Up with a Manufacturing Solution for Pandemic Flu Vaccines
Collaborators aim to produce vaccines in cell culture in half the time of traditional egg-based facilities. Full Story

Dec 10 2007, 01:14 PM EST
Eisai Snags MGI Pharma for $3.9B
Acquisition bolsters firm's revenues, pipeline, and U.S. presence. Full Story

GenEngNews.com